Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1.
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Sitagliptin (Primary) ; Enalaprilat
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Aim-1
- 10 Jun 2017 Biomarkers information updated
- 12 Oct 2015 Status changed from recruiting to completed.
- 17 Jun 2013 Planned end date changed from 1 May 2015 to 1 May 2014 as reported by ClinicalTrials.gov.